Dr. Bharathy E. Sundaram, MD

Dr. Sundaram practices at Texoma Neurology Associates, PA in Sherman, Texas.

Dr. Sundaram's NPI, 1396743720, was assigned on July 10, 2005. Dr. Sundaram graduated from Madras Medical College in 1985. Dr. Sundaram holds Texas license J7219.

Dr. Sundaram's primary practice is Texoma Neurology Associates, PA, at 321 N Highland Ave, Sherman, TX 75092 in Grayson County. The practice phone is (903) 893-5141.

Dr. Sundaram's primary practice is Texoma Neurology Associates, PA in Sherman, Texas. Dr. Sundaram is also affiliated with Baylor Scott & White Institute for Rehabilitation - Dallas. The medical group on file is Texas Institute for Neurological Disorders. Dmand AI also links Dr. Sundaram to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sundaram practices, 6 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Sundaram's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Sundaram is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Sundaram's licenses on file in 3 states: Texas, Oklahoma and Missouri.

Dmand AI lists acute mini-stroke (TIA), alzheimer's disease, carpal tunnel syndrome, cerebrovascular disease, encephalopathy, epilepsy, essential tremor and fibromyalgia and chronic pain among the conditions Dr. Sundaram treats.

CMS data shows 90,340 Medicare services from Dr. Sundaram across 42 procedure codes in 2024, for 794 Medicare patients. Medicare paid $1,061,069 for them. Every service was in an office.

CMS counts 794 Medicare patients who saw Dr. Sundaram in 2024. The largest group is 65 to 74, with 315 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sundaram's median patient age at 65, with 65% women.

In 2024, Dr. Sundaram wrote 5,589 Medicare Part D claims for 651 patients. 79% of them were for generic drugs. CMS names the drug for 5,237 of them, across 107 drugs with 11 or more claims each, at $4,713,309 in total drug cost. In 2023, CMS named 5,011 claims across 102 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Sundaram for performance year 2024, reported individually. Dr. Sundaram accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sundaram as offering telehealth. CMS counts 62 procedures of skin biopsy by Dr. Sundaram, more than 71% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Sundaram in 2021. 2021 was the busiest year, with 2. Dr. Sundaram's most frequent co-authors are Silvia R. Delgado, Derrick Scott Robertson, MD and Edward J. Fox, MD, PhD.

Dmand AI links Dr. Sundaram to 1 clinical trial. Conditions studied include Delusions and Hallucinations. Open Payments lists research payments to Dr. Sundaram that name 1 trial.

CMS Open Payments shows 642 general payments to Dr. Sundaram from 56 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 45% of the total. Sanofi and Genzyme US Companies paid the most, $75,605. It also lists 4 research payments totaling $4,204 from 2019 to 2021, naming 1 clinical trial.

Dmand AI lists 1 award for Dr. Sundaram, most recently CMS Stage 1 EHR in 2013.

Dr. Sundaram graduated from Madras Medical College in 1985. Dr. Sundaram is a member of MDS.

Dr. Sundaram is in network with 21 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.